But they also voiced concerns that some patients may not need all the drugs they are on and were potentially at increased risk of death.

Researcher Dr Carl Brayne said: “We know that polypharmacy is associated with higher mortality and that the evidence for combination therapies on the scale that we have seen them in the older population is not good.”